Friday, February 22, 2019

MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Issues Update on Jamaican Operations


Cannabis-focused research and development company the Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) today provided a detailed update regarding its Jamaican partner Epican Medicinals Ltd., a fully integrated cannabis company with cultivation, extraction, manufacturing and retail distribution licenses. TGODF acquire a 49.18% interest in Epican in June 2018 and has seen substantial progress toward expanding cultivation, opening additional retail dispensaries, and creating a leadership position in Jamaica’s medical cannabis market. Among other highlights from the update, the company reported that it has accelerated productive capacity while building inventory in preparation of its planned retail expansion. It has secured locations in Montego Bay and Negril for the strategic second and third retail locations. The Montego Bay retail location is complete and ready to open upon authorization from the Cannabis Licensing Authority. Added locations, including Negril, are planned for 2019 and 2020. “We have made incredible progress in Jamaica over the past 8 months,” TGODF Director and CEO Brian Athaide stated in the news release. “We plan to continue opening stores throughout the country, increasing productive capacity, and expanding our leadership in Jamaica. As Trelawny comes online in phases, we will accelerate production to meet growing demand within Jamaica and export product through TGOD’s distribution channels in Mexico and beyond.”

To view the full press release, visit http://ibn.fm/aCBN1

About the Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html